Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion-Reference-Cited by-同舟云学术

Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion

Published:2017-06 Issue:6 Volume:39 Page:101042831770584
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumour Biol.

Author:

Huang Dandan¹,Du Changzheng¹,Ji Dengbo¹,Xi Jianzhong²,Gu Jin¹

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery III, Peking University Cancer Hospital & Institute, Beijing, China

2. Department of Biomedical Engineering, College of Engineering, Peking University, Beijing, China

Funder

National Natural Science Foundation of China

Publisher

IOS Press

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1010428317705849

Reference20 articles.

1. Global cancer statistics

2. Cancer Statistics, 2009

3. NCBI GEO: archive for functional genomics data sets—update

4. A long non-coding RNA signature to improve prognosis prediction of colorectal cancer

5. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer;Frontiers of Medicine;2024-08-27

2. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway;Journal of Cancer Research and Clinical Oncology;2024-05-04

3. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer;Cell Reports;2024-03

4. Title: LAMC2 promotes oral squamous cell carcinoma growth by activating the p-ERK/c-Myc signaling pathway;2023-11-15

5. LAMC2 is a potential prognostic biomarker for cholangiocarcinoma;Oncology Letters;2023-10-30